Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01715519 · ClinicalTrials.gov registry record · Phase 4
Vilazodone for the Treatment of Posttraumatic Stress Disorder
A Phase 4 study, sponsored by Southern California Institute for Research and Education.
- Completed
- Registry status
- Phase 4
- Development phase
- 59
- Enrollment target
NCT01715519: Completed Phase 4 study, sponsored by Southern California Institute for Research and Education.
NCT01715519 is a Phase 4 study that has completed, run by Southern California Institute for Research and Education. The registered enrollment target is 59 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01715519, a Phase 4 study, has completed, sponsored by Southern California Institute for Research and Education.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether vilazodone is effective in the treatmen of Posttraumatic Stress Disorder (PTSD)and co-morbid mild or more depression.
Primary Outcome
PCL-C
Interventions
- DRUG Treatment (Viibryd)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2012-10 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
What the finished NCT01715519 record still lists
NCT01715519 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Treatment (Viibryd) is the first listed.
NCT01715519 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01715519 about?
NCT01715519 is a clinical study titled "Vilazodone for the Treatment of Posttraumatic Stress Disorder". The purpose of this study is to determine whether vilazodone is effective in the treatmen of Posttraumatic Stress Disorder (PTSD)and co-morbid mild or more depression.
What is the current status of trial NCT01715519?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 59 participants. The study started on 2012-10. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01715519?
The interventions under investigation include: Treatment (Viibryd) (DRUG).
Who is sponsoring clinical trial NCT01715519?
This trial is sponsored by Southern California Institute for Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01715519's enrollment target sits among peer trials
59 1202nd of 2000 higher than 796 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia